[go: up one dir, main page]

CN111795877A - Digital quality control method for chromaticity of fructus psoraleae - Google Patents

Digital quality control method for chromaticity of fructus psoraleae Download PDF

Info

Publication number
CN111795877A
CN111795877A CN202010654420.7A CN202010654420A CN111795877A CN 111795877 A CN111795877 A CN 111795877A CN 202010654420 A CN202010654420 A CN 202010654420A CN 111795877 A CN111795877 A CN 111795877A
Authority
CN
China
Prior art keywords
chromaticity
psoraleae
psoralen
control method
quality control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010654420.7A
Other languages
Chinese (zh)
Inventor
励娜
陈一龙
李胜容
储瑞
谭溧
王丹
王贤英
蒋振华
杜洪飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Academy of Chinese Materia Medica
Original Assignee
Chongqing Academy of Chinese Materia Medica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Academy of Chinese Materia Medica filed Critical Chongqing Academy of Chinese Materia Medica
Priority to CN202010654420.7A priority Critical patent/CN111795877A/en
Publication of CN111795877A publication Critical patent/CN111795877A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/3103Atomic absorption analysis

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Spectrometry And Color Measurement (AREA)

Abstract

一种补骨脂色度数字化质量控制方法,通过色度数字化方法对补骨脂的炮制品质进行鉴定,主要为:采用刺激值直读法或分光测色法测定出三刺激值X、Y、Z;3)将三刺激值X、Y、Z计算给出L*,a*,b*;4)通过L*,a*,b*在坐标系中的位置判断补骨脂药材或饮片的品质。补骨脂的色度可以容易区别补骨脂品种及不同的炮制方法,特别有效对补骨脂饮片及炮制品进行鉴定。该方法,操作简单、缩短时间,低成本、可行广泛普及,可作为补骨脂药材炮制质量评价依据。

Figure 202010654420

A chromaticity digital quality control method of Psoraleae, which is used to identify the processing quality of Psoraleae through a chromaticity digital method, mainly comprising: using a stimulus value direct reading method or a spectrophotometric method to measure tristimulus values X, Y, Z; 3) Calculate the tristimulus values X, Y, Z to give L * , a * , b * ; 4) Judge the psoralen medicinal material or the decoction piece by the position of L * , a * , b * in the coordinate system quality. The chromaticity of Psoraleae can easily distinguish Psoralea varieties and different processing methods, and is especially effective for identifying Psoralea decoction pieces and processed products. The method has the advantages of simple operation, shortened time, low cost, feasibility and widespread popularization, and can be used as a basis for quality evaluation of the processing of Psoraleae medicinal materials.

Figure 202010654420

Description

一种补骨脂色度数字化质量控制方法A kind of psoralen chromaticity digital quality control method

技术领域technical field

本发明涉及一种中药材鉴别方法,更具体的说涉及一种补骨脂色度数字化质量控制方法。The invention relates to a method for identifying traditional Chinese medicinal materials, and more particularly to a method for digital quality control of psoralen chroma.

背景技术Background technique

中药材是来源于植物类、动物类及矿物类的新鲜品或经过简单加工的药用部位,直接用于医疗保健或作为医药用原料的天然药物。对西洋医药异物同名品有很多;在市场容易出现类似品、赝品;中药材同一品种中,每一个体的品质不同;“天然中药材”和“栽培中药材”的作用程度不一定;大部分的中药材“产量”不可控制;难以保持价格的稳定性.品质不稳定,产量、价格也不稳定;但另外方面,缓慢、持续、缓和效果与作用;对应病症和体质,副作用少,停药后的症状是稳定。特别有根据中医理论悠久的临床经验来的效果保证。Chinese medicinal materials are fresh products or simply processed medicinal parts derived from plants, animals and minerals, and are directly used in medical care or as natural medicines as raw materials for medicine. There are many foreign medicines with the same name in Western medicine; similar products and counterfeit products are prone to appear in the market; in the same variety of Chinese medicinal materials, the quality of each individual is different; The "yield" of Chinese medicinal materials is uncontrollable; it is difficult to maintain the stability of the price. The quality is unstable, and the output and price are also unstable; but on the other hand, the slow, continuous, alleviating effect and effect; corresponding to the disease and constitution, with few side effects, stop the drug Post-symptoms were stable. In particular, the effect is guaranteed based on the long-standing clinical experience of traditional Chinese medicine theory.

中药材作为药品存在的问题:使用药食同源类的中药材应该选用基源正、且在质量上得到保障的药材。中药材为多成分复合体,通过成分间的相互作用显现出药效来。准确鉴别、评价某种中药材并非易事。Problems existing in Chinese herbal medicines as medicines: Chinese herbal medicines with the same origin as medicine and food should be selected from the origin and quality guaranteed. Chinese herbal medicines are multi-component complexes, which show their efficacy through the interaction between the components. It is not easy to accurately identify and evaluate a Chinese herbal medicine.

中药材的鉴别与评价方法:药用中药材具有悠久的历史,中药材的鉴别和评价以观察为主,进而通过化学反应、病理造模反应以及化学成分和基因等加以解析。(表1)Identification and evaluation methods of Chinese herbal medicines: Chinese herbal medicines have a long history. The identification and evaluation of Chinese herbal medicines are mainly based on observation, and then analyzed by chemical reactions, pathological modeling reactions, chemical components and genes. (Table 1)

表1.各种鉴别和质量评价法的特征Table 1. Characteristics of various identification and quality assessment methods

Figure BDA0002576173340000011
Figure BDA0002576173340000011

Figure BDA0002576173340000021
Figure BDA0002576173340000021

目前正处于研究的评价方法涉及多方面,但可以说决定性的有效的评价方法仍在摸索之中。此时采用自古以来的评价方法就有一定的道理了。过去对中药材的鉴定和质量评价是通过经验丰富而熟练者以中药材的颜色、气味、味觉、触感、形状、大小、轻重为依据鉴别、评价质量。植物因品种不同,其颜色、气味、味觉、触感等都有特征。古人从积累的经验中领会并能鉴别出品种特征的差异,再基于丰富的行医经验以同种药材细微的差异为线索选择有疗效的中药材。The evaluation methods currently under study involve many aspects, but it can be said that a decisive and effective evaluation method is still being explored. At this time, it makes sense to use the evaluation method since ancient times. In the past, the identification and quality evaluation of Chinese herbal medicines were based on the color, smell, taste, touch, shape, size and severity of Chinese herbal medicines by experienced and skilled people. Plants are different in color, smell, taste, touch and so on. The ancients learned from the accumulated experience and were able to identify the differences in the characteristics of the varieties, and then based on the rich experience in practicing medicine, the subtle differences of the same medicinal materials were used as clues to select Chinese medicinal materials with curative effects.

但,人的感觉器官和感受能力各不相同,人的状态不同也会影响判断结果。依靠颜色、气味、味觉、触感等感觉去判断同样的对象,作出判断的人和他自身的状态以及当时的环境情况对香型、味觉的感受是有差异的。另,各国的现行药典也登载有颜色、气味、味觉,作为鉴别时的可用信息。但,几乎所有的药典中的色泽表述都是习惯用句,表述不一致。而习惯用句对色泽的表述其解释又因人而异。However, people's sense organs and perception abilities are different, and different people's states will also affect the judgment results. Relying on the senses of color, smell, taste, touch, etc. to judge the same object, the person who makes the judgment and his own state and the environment at that time have different perceptions of aroma and taste. In addition, the current pharmacopoeia of each country also publishes color, odor, and taste as information that can be used for identification. However, almost all the color expressions in the pharmacopoeia are idioms, and the expressions are inconsistent. And the interpretation of color expression in customary sentences varies from person to person.

为了活用古代的鉴别方法必须客观认识色泽、并客观表现出统一的表示法。而生药资源现在已经不仅仅只是考虑中国国内的问题,应考虑它是在世界领域流通的药用资源。因此期望中药材颜色的表述有一个世界统一的标准出台。In order to make use of the ancient identification methods, it is necessary to objectively recognize the color and lustre, and objectively express a unified representation. And crude drug resources are not only considered domestic problems in China, but should be considered as medicinal resources circulating in the world. Therefore, it is expected that there will be a unified world standard for the expression of the color of Chinese medicinal materials.

显示中药材的颜色需要「中药材」、「光源」、「視覚」。中药材从照射的光源处吸收一部分光,反射多余的光。反射光进入视线范围,人们就会将特定波长的光作为颜色加以感受。因物体发生反射,视觉才能辨析带色的光,这种光与各种波长成分相交集。我们可以看到的是可视光线领域波长(380nm~780nm)的光。但,光不是色,光是定义「刺激眼的视网膜引起视觉放射」,进入眼睛的光使视网膜受到刺激,大脑对此作出反应。对光谱中的「赤」、「青」、「緑」(三原色)的感觉全在我们的视网膜上,所以产生了色的概念。To display the color of Chinese herbal medicines, "Chinese herbal medicines", "Light source", and "Sightseeing" are required. Chinese herbal medicines absorb part of the light from the irradiated light source and reflect the excess light. When reflected light enters the line of sight, people perceive light of a specific wavelength as a color. Due to the reflection of objects, vision can distinguish colored light, which intersects with various wavelength components. What we can see is light with wavelengths in the visible light range (380nm to 780nm). However, light is not a color. Light is defined as "stimulating the retina of the eye to cause visual radiation." Light entering the eye causes the retina to be stimulated, and the brain responds to it. The perception of "red", "cyan" and "green" (the three primary colors) in the spectrum is all on our retina, so the concept of color is born.

不同光源下观察中药材,不同表面形状的中药材,不同观察方向,不同照明位置又中药材大小及在室内的明暗及温度等不同测定环境、不同观察者所引起的视觉差,特殊色彩的不规则反射和吸收引起视觉差等,成色一致的看上去也有很多不同。Observation of Chinese herbal medicines under different light sources, Chinese herbal medicines with different surface shapes, different observation directions, different lighting positions, the size of Chinese herbal medicines, indoor light and shade and temperature, etc. Regular reflection and absorption cause visual difference, etc., and the same color looks different.

如:中药材面积大比小,觉得鲜亮(颜色的面积效果),亮的背景比暗的背景中药材觉得颜色不同(对比效果)等。For example, the area of the Chinese herbal medicine is larger than the smaller, and it feels bright (the area effect of the color), and the Chinese herbal medicine on a bright background is different in color than the dark background (contrast effect).

随时代的发展表示颜色的用语会发生变化。而珊瑚色、粉红色等习惯色名可以沿用。暗红、鲜红等在体系色名之前冠以形容词构成的体系色名,可将所有的颜色系统地分类加以表示。总之,颜色的准确表示难以到位。所以期望给色调、明度、彩度制定各自特有的标准,使颜色数字化,以免产生认识上的误解。The terminology for color changes over time. The customary color names such as coral and pink can be used. System color names such as dark red and bright red are prefixed with adjectives before the system color name, and all colors can be classified and represented systematically. In short, accurate representation of colors is difficult to achieve. Therefore, it is expected to formulate their own unique standards for hue, lightness, and chroma to digitize colors to avoid misunderstandings in understanding.

研究以颜色为体系建立数值表示法,即制定颜色标准的研究于1905年由美国画家阿尔巴特H.曼瑟尔首次提出,其后创作出[色调][明度][彩度]各不相同的色纸,以此对比进行分类表示颜色的“曼瑟尔表色系统”使用色调(H)、明度(V)、彩度(C)分类色票以代码解读颜色。The study of using color as a system to establish a numerical representation, that is, the study of formulating color standards was first proposed by the American painter Albert H. Mansell in 1905, and then he created different [hue] [lightness] [chroma]. The "Mansell Color System" that is used to classify and express colors using color paper, uses hue (H), lightness (V), and chroma (C) classification chips to interpret colors by code.

近代,与色、光相关的国际性协商机构——国际标准化团体:组建了国际照明委员会(CIE:Commission International de I‘Eclairege)。CIE于1931年制定“XYZ(Yxy)表色系统”、1976年制定“L*a*b*表色系统(CIE1976Lab表色系统)”。采用这些表色系统使全球用统一的色度表示成为可能。In modern times, an international consultative body related to color and light, the International Organization for Standardization, established the International Commission on Illumination (CIE: Commission International de I'Eclairege). CIE formulated the "XYZ (Yxy) color system" in 1931, and the "L*a*b* color system (CIE1976Lab color system)" in 1976. The adoption of these colorimetric systems makes it possible to express uniform chromaticity worldwide.

现目前表色系统的种类除上述之外,还有RGB表色系统,xyY表色系统,奥斯托瓦尔德表色系统,NCS(Natural Color System)表色系统,DIN表色系统,RGBA表色系统,CMY表色系统,CMYK表色系统,CMK表色系统,HSV表色系统,HLS表色系统等,其中,最为广泛使用的是“L*a*b*表色系统(CIE1976Lab表色系统)”。目前目测法最为常用,成本低,操作简便,但这一方法仅仅凭借实验者的感官判断药品质量,容易受实验者主观的影响,故不够科学严谨;紫外-可见分光光度法通常选择在某一特定波长处测定药品溶液颜色,而实际上,中药制剂成分复杂,药品溶液的颜色是不同波长共同作用的结果,故单单凭借一特定波长吸光值无法准确反映药品溶液颜色。In addition to the above, the current types of color systems include RGB color system, xyY color system, Ostwald color system, NCS (Natural Color System) color system, DIN color system, RGBA color system. Color system, CMY color system, CMYK color system, CMK color system, HSV color system, HLS color system, etc. Among them, the most widely used is the "L*a*b* color system (CIE1976Lab color system). system)". At present, the visual inspection method is the most commonly used, with low cost and simple operation. However, this method only relies on the experimenter's senses to judge the quality of the drug, and is easily affected by the experimenter's subjective influence, so it is not scientific and rigorous; UV-Vis spectrophotometry is usually selected in a certain The color of the drug solution is measured at a specific wavelength. In fact, the composition of traditional Chinese medicine preparations is complex, and the color of the drug solution is the result of the interaction of different wavelengths. Therefore, the color of the drug solution cannot be accurately reflected by the absorbance value of a specific wavelength.

中药炮制是以中医药辨证论治理论为指导,按用药需要或药物自身性味,以及制剂的不同需求所采取的制药技术;是中医药通过几千年来大量实践论证形成的科学体系;是中医药不断传承创新的体现。补骨脂为我国传统大宗药材品种,具有纳气平喘、温肾助阳、温脾止泻的功效。早在《开宝本草》中就有药性记载,至今已有一千多年药用历史。现代研究表明,其主要指标成分(香豆素类、黄酮类、萜酚类等)具有雌激素样、抗菌、抗肿瘤、抗抑郁、抗氧化等生物活性。但补骨脂有燥毒,易伤阴助火。现代研究表明,补骨脂中有毒成分可致肾脏病理变化,大剂量可见进行性肾损伤。故临床用药多需炮制,以达到增效减毒的目的。The processing of traditional Chinese medicine is guided by the theory of syndrome differentiation and treatment of traditional Chinese medicine, and the pharmaceutical technology is adopted according to the needs of drug use or the nature and flavor of the drug itself, as well as the different needs of preparations; it is a scientific system formed by traditional Chinese medicine through thousands of years of practical demonstrations; it is traditional Chinese medicine. The embodiment of continuous inheritance and innovation. Psoralea is a traditional bulk medicinal material in my country. It has the effects of invigorating Qi and relieving asthma, warming kidney and helping yang, warming spleen and stopping diarrhea. As early as "Kaibao Materia Medica" has medicinal records, it has a history of more than one thousand years of medicinal use. Modern research shows that its main index components (coumarins, flavonoids, terpene phenols, etc.) have estrogen-like, antibacterial, antitumor, antidepressant, antioxidant and other biological activities. But psoralen is dry and poisonous, and it is easy to hurt the yin and help the fire. Modern research has shown that the toxic components in Psoraleae can cause pathological changes in the kidneys, and progressive kidney damage can be seen in large doses. Therefore, many clinical drugs need to be concocted to achieve the purpose of increasing efficacy and reducing toxicity.

补骨脂的炮制方法,最早记载于南北朝《雷公炮制论》中,以酒浸蒸除燥毒是药材炮制的目的,后世称此法为“雷公法”。而盐炙法最早见于宋代《局方》,是为了改进炮制工艺复杂的雷公炮制法而提出的。随后元代《儒门事亲》中也有用加盐炒炙减毒的炮制方法记载。到了明代,盐炙法有了较大的发展,《禁方》中用盐水浸来炙,《寿世保元》中则是用盐水炒。清代补骨脂盐炙有了明确时间规定“泡一夜”、“浸一日”、“浸三日”的记载,还有盐汤热浸的记载。后世医家在盐炙上所进行的逐步改进,如“微炒”、“盐炒”、“盐水浸炒”、“与他药合制”均以去燥毒为目的。The processing method of psoraleae was first recorded in the Southern and Northern Dynasties "Leigong Processing Theory". The salt-burning method was first seen in the "Jufang" of the Song Dynasty, which was proposed to improve the Leigong processing method with complex processing technology. Later, in the Yuan Dynasty "Confucianism", there was also a record of the processing method of adding salt, frying, and reducing poison. In the Ming Dynasty, the method of salt-roasting has been greatly developed. In the "Forbidden Prescription", it is immersed in salt water for baking, and in "Shou Shi Bao Yuan", it is fried in salt water. In the Qing Dynasty, there were records of "soaking for one night", "soaking for one day" and "soaking for three days", and records of hot soaking in salt soup. The step-by-step improvements made by later generations of physicians in salt roasting, such as "micro-fried", "salted stir-fry", "salt-soaked stir-fry", and "combined with other medicines" are all aimed at removing dryness and toxins.

从1963年版《中国药典》开始,就有了补骨脂炮制项的收载,其工艺为:取补骨脂置锅内,用盐水微润,拌匀,并用文火炒至微鼓起,取出放冷,晾干,即得。其后三版药典在炮制中增加了以“盐水喷洒均匀”的方法,至1990年版药典对盐炙法内容均是稍有改动,并逐步细化。1990年版至今,补骨脂炮制法均采用《中国药典》附录炮制通则中盐炙法项下执行。Since the 1963 edition of the "Chinese Pharmacopoeia", there has been a collection of the processing items of Psoraleae. Let cool, let dry, and serve. The following three editions of the Pharmacopoeia added the method of "spraying salt water evenly" in the processing. By the 1990 edition of the Pharmacopoeia, the content of the salt-burning method was slightly changed and gradually refined. Since the 1990 edition, the processing method of Psoraleae has been implemented under the salt-burning method in the General Principles of Processing in the appendix of the Chinese Pharmacopoeia.

发明内容SUMMARY OF THE INVENTION

补骨脂酚为补骨脂的毒性成分,在补骨脂醚提取物中含量占50%以上,为补骨脂不良反应的主要物质;上述补骨脂市售饮片及药材原料生品和盐炙品不易区分问题,本发明通过色差仪测定补骨脂原药材及提取物的颜色,并对补骨脂的饮片的毒性进行判断,并据此判断补骨脂院药材是否炮制合格,本发明提供的一种补骨脂色度数字化质量控制方通过依托CIELab色空间,用CIE Lab三维坐标中一个特定的点来表示某一特定的颜色,这一方法操作简便,准确度高,判断精准。包括以下步骤:Bakuchiol is the toxic component of Bakuchiol, which accounts for more than 50% in the Bakuchiol ether extract, and is the main substance in the adverse reaction of Bakuchiol; the above-mentioned Bakuchiol commercially available decoction pieces and raw medicinal materials and salts It is difficult to distinguish the sunburned products. In the present invention, the color of the original Psoraleae medicinal material and the extract is measured by a colorimeter, and the toxicity of the decoction pieces of Psoralea japonicus is judged. The provided digital quality control method for psoralen chroma uses a specific point in the CIE Lab three-dimensional coordinates to represent a specific color by relying on the CIELab color space. Include the following steps:

1)将补骨脂药材或饮片粉碎,得到待检物料;1) pulverize the Psoraleae medicinal material or decoction pieces to obtain the material to be inspected;

2)将待检物料置于比色皿中,采用刺激值直读法或分光测色法测定出三刺激值X、Y、Z;2) The material to be tested is placed in a cuvette, and the tristimulus values X, Y, and Z are measured by the direct reading method of the stimulus value or the spectrophotometric method;

3)将三刺激值X、Y、Z计算给出L*,a*,b*3) Calculate the tristimulus values X, Y, and Z to give L * , a * , b * ;

4)通过L*,a*,b*在坐标系中的位置判断补骨脂药材或饮片的品质。4) Judging the quality of Psoraleae medicinal materials or decoction pieces by the positions of L * , a * , b * in the coordinate system.

测定条件为:扩散照明方式;反射光;光源:ID65光;观察视野:10°;表色系:CIE L*a*b*表色系;起止波长:780~360nm;扫描速度:600nm/min;狭缝宽度:1nm;专用比色皿12mm*10mm;测定値:采用5次测定后的平均値。Measurement conditions are: diffuse illumination; reflected light; light source: ID65 light; observation field: 10°; color system: CIE L*a*b* color system; start and end wavelength: 780~360nm; ; Slit width: 1nm; Special cuvette 12mm*10mm; Measurement value: the average value after 5 measurements.

步骤4)通过判断a*,b*的在坐标系中的位置区间,判断待检物料的品种是否经炮制合格。Step 4) By judging the position intervals of a * and b * in the coordinate system, it is judged whether the variety of the material to be inspected is qualified through processing.

其中,CIEL*a*b*色空间系统中a*和b*表示不同的色调方向,a*表示红绿方向,+a*表示红方向,-a*表示绿方向;b*表示黄蓝方向,+b*表示黄方向,-b*表示蓝方向;L*表示明度,L*越大明度越大,L*越小,明度越小。Among them, in the CIEL*a*b* color space system, a* and b* represent different hue directions, a* represents the red and green direction, +a* represents the red direction, -a* represents the green direction; b* represents the yellow and blue direction , +b* represents the yellow direction, -b* represents the blue direction; L* represents the lightness, the larger the L*, the greater the lightness, the smaller the L*, the smaller the lightness.

b*的色度低于22.5的物料为炮制合格产品。Materials with b* chroma lower than 22.5 are qualified products.

本发明的有益技术效果是:补骨脂的色度可以容易区别补骨脂品种及不同的炮制方法,特别有效对补骨脂饮片及炮制品进行鉴定。该方法,操作简单、缩短时间,低成本、可行广泛普及,可作为补骨脂药材炮制质量评价依据。The beneficial technical effects of the invention are: the chromaticity of psoraleae can easily distinguish psoralea varieties and different processing methods, and is particularly effective for identifying psoralea decoction pieces and processed products. The method has the advantages of simple operation, shortened time, low cost, feasibility and widespread popularization, and can be used as a basis for quality evaluation of the processing of Psoraleae medicinal materials.

附图说明Description of drawings

图1补骨脂盐炙前后差异;Fig. 1 The difference before and after psoralen salt roasting;

图2补骨脂盐炙前后醚浸出物和L*(D65)差异;Fig. 2 The difference of ether extract and L*(D65) before and after psoralen salt-burning;

图3补骨脂盐炙前后醚浸出物和a*(D65)差异;Fig. 3 The difference of ether extract and a*(D65) before and after psoralen salt-burning;

图4补骨脂盐炙前后醚浸出物和b*(D65)差异。Fig. 4 The difference of ether extract and b*(D65) before and after psoralen salt-burning.

具体实施方式Detailed ways

实施例1Example 1

1补骨脂样品的制备1 Preparation of psoralen samples

补骨脂药材为重庆市中药研究院生药研究所在进行全国药材资源普查时在全国各大中药材市场收集,共计15批,来源于5个产地,13个饮片厂。Psoraleae medicinal materials were collected from major Chinese medicinal material markets across the country during the national medicinal material resource census conducted by the Institute of Crude Medicine of Chongqing Institute of Traditional Chinese Medicine. There are 15 batches in total, originating from 5 origins and 13 decoction pieces factories.

上述15批药材均经李隆云研究员(重庆市中药研究院)鉴定为豆科植物补骨脂Psoralea corylifolia Linn.的干燥成熟果实。将上述在炮制工艺的辅料用量上,100kg补骨脂用盐量为2kg;“炒至微鼓起”,得到盐补骨脂。样品信息见表1。The above 15 batches of medicinal materials were all identified by researcher Li Longyun (Chongqing Institute of Traditional Chinese Medicine) as the dried and ripe fruits of the leguminous plant Psoralea corylifolia Linn. In the above-mentioned dosage of auxiliary materials in the processing technology, the amount of salt used in 100kg of Psoraleae is 2kg; See Table 1 for sample information.

表1补骨脂样品信息表Table 1 Psoralea sample information table

Figure BDA0002576173340000051
Figure BDA0002576173340000051

取供试品(过四号筛)2~5g,精密称定,置五氧化二磷干燥器中干燥12小时,里索氏提取器中,加乙醚适量,除另有规定外,加热回流8小时,取乙醚液,置干燥至恒重的蒸发皿中,放置,挥去乙醚,残渣置五氧化二磷干燥器中干燥18小时,精密称定,缓缓加热至105℃,并于105℃干燥至恒重。其减失重量即为挥发性醚浸出物的重量。测定方法及结果见下表2。Take 2-5 g of the test product (passed through a No. 4 sieve), accurately weigh it, and place it in a phosphorus pentoxide desiccator for 12 hours. Add an appropriate amount of diethyl ether to a Lisoxhlet extractor, and heat to reflux for 8 unless otherwise specified. After 2 hours, take the ether solution, put it in an evaporating dish that is dried to constant weight, put it aside, evaporate the ether, and dry the residue in a phosphorus pentoxide desiccator for 18 hours, accurately weigh it, slowly heat it to 105 ° C, and heat it at 105 ° C Dry to constant weight. The weight loss is the weight of the volatile ether extract. The measurement method and results are shown in Table 2 below.

表2补骨脂盐制前后挥发性醚浸出物Table 2 Volatile ether extracts before and after Psoralea salt preparation

Figure BDA0002576173340000061
Figure BDA0002576173340000061

2HPLC方法的考察2. Investigation of HPLC method

HPLC方法测定15批补骨脂药材、15批饮片的补骨脂酚含量测定,结果见表3。色谱条件为:选择色谱柱Boston Symmetrix ODS-R(250×4.6mm,5μm),流动相为乙腈-纯水、流速为1.0mL/min、柱温为30℃,检测波长254nm时能较好的分离补骨脂酚,且系统适应性能达到要求。HPLC method was used to determine the content of bakuchiol in 15 batches of Bakuchi and 15 batches of decoction pieces. The results are shown in Table 3. The chromatographic conditions are as follows: select the chromatographic column Boston Symmetrix ODS-R (250×4.6mm, 5μm), the mobile phase is acetonitrile-pure water, the flow rate is 1.0mL/min, the column temperature is 30℃, and the detection wavelength is 254nm. The bakuchiol was separated, and the adaptability of the system met the requirements.

表3补骨脂盐制前后补骨脂酚含量Table 3 Bakuchiol content before and after bakuchiol salt preparation

Figure BDA0002576173340000062
Figure BDA0002576173340000062

Figure BDA0002576173340000071
Figure BDA0002576173340000071

由表3可知补骨脂药材补骨脂酚在331.6022-567.8895mg/g,饮片盐补骨脂酚含量在323.8859~506.4792mg/g。It can be seen from Table 3 that the bakuchiol content of Bakuchiol is 331.6022-567.8895 mg/g, and the content of bakuchiol in the decoction salt is 323.8859-506.4792 mg/g.

通过HPLC含量测定发现补骨脂炮制后补骨脂酚的含量减少,补骨脂中含量最大的成分为补骨脂酚,所以毒性相应减弱。炮制后补骨脂素和异补骨脂素等有效成分增加(如补骨脂苷类加热等过程中分解成产生补骨脂素和异补骨脂素),故通过醚浸出物和补骨脂酚含量测定可以有效的对补骨脂药材及饮片的质量进行控制。The content of bakuchiol decreased after the processing of bakuchiol by HPLC. The most abundant component in bakuchiol was bakuchiol, so the toxicity was weakened accordingly. After processing, the active ingredients such as psoralen and isopsoralen increase (for example, psoralen is decomposed into psoralen and isopsoralen in the process of heating, etc.), so the ether extract and psoralen Determination of lipid phenol content can effectively control the quality of Psoraleae medicinal materials and decoction pieces.

3补骨脂中色度测定方法研究3. Study on the determination method of psoralen in color

仪器与材料:测色计CM-5(日本KONICAMINOLTA)、补骨脂药材(过3号筛)、补骨脂盐炙饮片(过3号筛)。Instruments and materials: Colorimeter CM-5 (KONICAMINOLTA, Japan), Psoralea medicinal material (passed through No. 3 sieve), and fried pieces of Psoralea salt (passed through No. 3 sieve).

测定方法:L*a*b*表色系:在360nm-740nm波长下分解物体反射的光,在按照一定的规律,并转换为3个数字L*a*b*,L*(0.00-100.00)是代表明度,a*及b*代表色相。测定条件:扩散照明(积分球)方式;反射光;光源:ID65光;观察视野:10°;表色系:CIE L*a*b*表色系(CIE);起止波长:780~360nm;扫描速度:600nm/min;狭缝宽度:1nm;专用比色皿12mm*10mm;测定値:采用5次测定后的平均値。Measurement method: L*a*b* color system: decompose the light reflected by the object at the wavelength of 360nm-740nm, and convert it into 3 numbers L*a*b*, L*(0.00-100.00 ) represents lightness, and a* and b* represent hue. Measurement conditions: diffuse illumination (integrating sphere) method; reflected light; light source: ID65 light; observation field: 10°; color system: CIE L*a*b* color system (CIE); Scanning speed: 600nm/min; slit width: 1nm; special cuvette 12mm*10mm; measurement value: the average value after 5 measurements.

按照色度测定方法测定15批补骨脂药材、15批饮片的色度,结果见表4。The chromaticity of 15 batches of Psoraleae medicinal materials and 15 batches of decoction pieces was measured according to the chromaticity measurement method, and the results are shown in Table 4.

表4补骨脂盐制前后色度测定结果Table 4 chromaticity measurement results before and after psoralen salt preparation

Figure BDA0002576173340000072
Figure BDA0002576173340000072

其中,b*值取平均值为21.175,然后用该组数据的算数平均值的绝对偏差平均值作为上下浮动的范围(avedev值为2.596),范围即为21.175±2.596)Among them, the average value of b* value is 21.175, and then the average value of absolute deviation of the arithmetic average of this group of data is used as the range of up and down (avedev value is 2.596), and the range is 21.175±2.596)

4补骨脂盐炙前后色度差异性分析4. Analysis of the difference in chromaticity before and after psoralea salt-burning

选择补骨脂药材和盐炙补骨脂饮片的色度a*(D65)、b*(D65)数据,以a*(D65)为横坐标,b*(D65)为纵坐标作图分析,见图1。Select the chromaticity a*(D65) and b*(D65) data of Psoraleae medicinal material and salt-cured Psoraleae decoction pieces, take a*(D65) as the abscissa and b*(D65) as the ordinate for graph analysis, see picture 1.

由图1可知,补骨脂药材在图中聚集在一起,相对集中,补骨脂盐炙饮片聚集在一起,相对分散,除了3个盐炙饮片偏差太大,补骨脂药材和盐炙饮片可以看出明显不同,各自分布在不同的区域,这说明补骨脂药材和盐炙饮片的色度是不同的,有明显差异。It can be seen from Figure 1 that the Psoraleae medicinal materials are clustered together and relatively concentrated in the figure, while the Psoralea salt decoction pieces are clustered together and relatively dispersed. It can be seen that there are obvious differences, and they are distributed in different regions, which shows that the chromaticity of Psoraleae medicinal material and salt-fried decoction pieces are different, and there are obvious differences.

5补骨脂盐炙前后色度与醚浸出物相关性分析5 Correlation analysis between chromaticity and ether extracts before and after psoralea salt-burning

选择补骨脂药材和盐炙补骨脂饮片的醚浸出物分别与色度L*(D65)、a*(D65)、b*(D65)数据作图分析。The ether extracts of Psoraleae medicinal materials and salt-cured Psoraleae decoction pieces were plotted and analyzed with chromaticity L*(D65), a*(D65), b*(D65) data respectively.

补骨脂醚浸出物分别与色度L*(D65)相关性:选择补骨脂药材和盐炙补骨脂饮片的醚浸出物分别与色度L*(D65)数据作图分析,以醚浸出物为横坐标,L*(D65)为纵坐标作图分析,见图2。Correlation between Psoralea ether extracts and chromaticity L*(D65): The ether extracts of Psoraleae medicinal material and salt-cured Psoraleae decoction pieces were plotted and analyzed with chromaticity L*(D65) data respectively. The leachate is the abscissa, and L*(D65) is the ordinate, as shown in Figure 2.

由图2可知,补骨脂药材在图中聚集在一起,呈长条状,L*(D65)数据变化较小,醚浸出物有变化,补骨脂盐炙饮片聚集在一起,相对集中,除了3个盐炙饮片偏差太大,补骨脂药材和盐炙饮片可以看出明显不同,各自分布在不同的区域,这说明补骨脂药材和盐炙饮片的醚浸出物有明显差异,色度L*(D65)差异较小。It can be seen from Figure 2 that the Psoraleae medicinal materials are clustered together in the figure, in the shape of long strips, the L*(D65) data has little change, the ether extract has changed, and the Psoralea salt-fried pieces are clustered together and relatively concentrated. In addition to the large deviation of the three salt-cured decoction pieces, it can be seen that the Psoraleae medicinal material and the salt-cured decoction piece are obviously different, and they are distributed in different regions, which shows that the ether extracts of the Psoraleae medicinal material and the salt-cured decoction piece are significantly different. The difference in degree L*(D65) is small.

补骨脂醚浸出物分别与色度a*(D65)相关性:选择补骨脂药材和盐炙补骨脂饮片的醚浸出物分别与色度a*(D65)数据作图分析,以醚浸出物为横坐标,a*(D65)为纵坐标作图分析,见图3。Correlation between Psoralea ether extracts and chromaticity a*(D65): The ether extracts of Psoraleae medicinal material and salt-cured Psoraleae decoction pieces were plotted and analyzed with chromaticity a*(D65) data, respectively. The leachate is the abscissa, and a*(D65) is the ordinate, as shown in Figure 3.

由图3可知,补骨脂药材在图中聚集在一起,呈长条状,a*(D65)数据变化较小,醚浸出物有变化,补骨脂盐炙饮片聚集在一起,相对集中,除了3个盐炙饮片偏差太大,补骨脂药材和盐炙饮片可以看出明显不同,各自分布在不同的区域,这说明补骨脂药材和盐炙饮片的醚浸出物有明显差异,色度a*(D65)差异较小。It can be seen from Figure 3 that the Psoraleae medicinal materials are clustered together in the figure, in the shape of long strips, the data of a*(D65) has little change, and the ether extract has changed. In addition to the large deviation of the three salt-cured decoction pieces, it can be seen that the Psoraleae medicinal material and the salt-cured decoction piece are obviously different, and they are distributed in different regions, which shows that the ether extracts of the Psoraleae medicinal material and the salt-cured decoction piece are significantly different. The degree a*(D65) is less different.

补骨脂醚浸出物分别与色度b*(D65)相关性:选择补骨脂药材和盐炙补骨脂饮片的醚浸出物分别与色度b*(D65)数据作图分析,以醚浸出物为横坐标,b*(D65)为纵坐标作图分析,见图4。Correlation between Psoralea ether extracts and chromaticity b*(D65): The ether extracts of Psoraleae medicinal material and salt-cured Psoraleae decoction pieces were plotted and analyzed with chromaticity b*(D65) data respectively. The leachate is the abscissa, and b*(D65) is the ordinate, as shown in Figure 4.

由图4可知,补骨脂药材在图中聚集在一起,呈长条状,b*(D65)数据变化较小,醚浸出物有变化,补骨脂盐炙饮片聚集在一起,相对集中,除了3个盐炙饮片偏差太大,补骨脂药材和盐炙饮片可以看出明显不同,各自分布在不同的区域,这说明补骨脂药材和盐炙饮片的醚浸出物有明显差异,色度b*(D65)有差异。It can be seen from Figure 4 that the Psoraleae medicinal materials are clustered together in the figure and are in the shape of long strips. The b*(D65) data has little change, and the ether extract has changed. In addition to the large deviation of the three salt-cured decoction pieces, it can be seen that the Psoraleae medicinal material and the salt-cured decoction piece are obviously different, and they are distributed in different regions, which shows that the ether extracts of the Psoraleae medicinal material and the salt-cured decoction piece are significantly different. There is a difference in degree b*(D65).

Claims (5)

1.一种补骨脂色度数字化质量控制方法,通过色度数字化方法对补骨脂的炮制品质进行鉴定,其特征在于:包括以下步骤:1. a psoralen chromaticity digitization quality control method, by chromaticity digitization method, the processing quality of psoralen is identified, it is characterized in that: comprise the following steps: 1)将补骨脂药材或饮片粉碎,得到待检物料;1) pulverize the Psoraleae medicinal material or decoction pieces to obtain the material to be inspected; 2)将待检物料置于比色皿中,采用刺激值直读法或分光测色法测定出三刺激值X、Y、Z;2) The material to be tested is placed in a cuvette, and the tristimulus values X, Y, and Z are measured by the direct reading method of the stimulus value or the spectrophotometric method; 3)将三刺激值X、Y、Z计算给出L*,a*,b*3) Calculate the tristimulus values X, Y, and Z to give L * , a * , b * ; 4)通过L*,a*,b*在坐标系中的位置判断补骨脂药材或饮片的品质。4) Judging the quality of Psoraleae medicinal materials or decoction pieces by the positions of L * , a * , b * in the coordinate system. 2.根据权利要求1所述的补骨脂色度数字化质量控制方法,其特征在于:测定条件为:扩散照明方式;反射光;光源:ID65光;观察视野:10°;表色系:CIE L*a*b*表色系;起止波长:780~360nm;扫描速度:600nm/min;狭缝宽度:1nm;专用比色皿12mm*10mm;测定値:采用5次测定后的平均値。2. psoralen chromaticity digital quality control method according to claim 1, is characterized in that: measuring condition is: diffuse illumination mode; Reflected light; Light source: ID65 light; Observation field: 10 °; L*a*b* color system; start and end wavelength: 780~360nm; scanning speed: 600nm/min; slit width: 1nm; 3.根据权利要求1所述的补骨脂色度数字化质量控制方法,其特征在于:步骤4)通过判断a*,b*的在坐标系中的位置区间,判断待检物料是否炮制合格。3. psoralen chromaticity digital quality control method according to claim 1, is characterized in that: step 4) by judging a * , the position interval in the coordinate system of b * , judge whether the material to be inspected is processed qualified. 4.根据权利要求2所述的补骨脂色度数字化质量控制方法,其特征在于:CIEL*a*b*色空间系统中a*和b*表示不同的色调方向,a*表示红绿方向,+a*表示红方向,-a*表示绿方向;b*表示黄蓝方向,+b*表示黄方向,-b*表示蓝方向;L*表示明度,L*越大明度越大,L*越小,明度越小。4. psoralen chromaticity digital quality control method according to claim 2, is characterized in that: in CIEL*a*b* color space system, a* and b* represent different hue directions, and a* represent red-green direction , +a* indicates the red direction, -a* indicates the green direction; b* indicates the yellow and blue direction, +b* indicates the yellow direction, -b* indicates the blue direction; L* indicates the lightness, the greater the L*, the greater the lightness, and the L *The smaller the lightness, the smaller the lightness. 5.根据权利要求3所述的补骨脂色度数字化质量控制方法,其特征在于:在18.58~23.77范围内的物料为炮制合格产品。5. The psoralen chromaticity digital quality control method according to claim 3, characterized in that: the materials within the range of 18.58~23.77 are processed qualified products.
CN202010654420.7A 2020-07-09 2020-07-09 Digital quality control method for chromaticity of fructus psoraleae Pending CN111795877A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010654420.7A CN111795877A (en) 2020-07-09 2020-07-09 Digital quality control method for chromaticity of fructus psoraleae

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010654420.7A CN111795877A (en) 2020-07-09 2020-07-09 Digital quality control method for chromaticity of fructus psoraleae

Publications (1)

Publication Number Publication Date
CN111795877A true CN111795877A (en) 2020-10-20

Family

ID=72810443

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010654420.7A Pending CN111795877A (en) 2020-07-09 2020-07-09 Digital quality control method for chromaticity of fructus psoraleae

Country Status (1)

Country Link
CN (1) CN111795877A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115326726A (en) * 2022-08-12 2022-11-11 粤海永顺泰(广州)麦芽有限公司 Malt chroma detection method

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103512848A (en) * 2013-05-27 2014-01-15 重庆市中药研究院 Digital quality detection method and equipment for chromaticity of rhizoma coptidis
CN104931428A (en) * 2015-05-26 2015-09-23 南京中医药大学 On-line control method for preparation process of fructus gardenia
CN107192676A (en) * 2017-07-20 2017-09-22 广东药科大学 A kind of method for differentiating sophora flower quality based on colour difference meter method
CN107389564A (en) * 2017-07-26 2017-11-24 成都中医药大学 A kind of method for differentiating stir-baked RHIZOMA ATRACTYLDIS MACROCEPHALAE in bran and processing the duration and degree of heating
CN110261323A (en) * 2019-06-21 2019-09-20 广东一方制药有限公司 An online evaluation method of dog ridge processing technology
CN110441255A (en) * 2019-08-27 2019-11-12 广东一方制药有限公司 A kind of detection method of processed products of Fructus Gardeniae
CN111323379A (en) * 2020-04-23 2020-06-23 山东省中医药研究院 A method for judging the processing quality of arborvitae charcoal

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103512848A (en) * 2013-05-27 2014-01-15 重庆市中药研究院 Digital quality detection method and equipment for chromaticity of rhizoma coptidis
CN104931428A (en) * 2015-05-26 2015-09-23 南京中医药大学 On-line control method for preparation process of fructus gardenia
CN107192676A (en) * 2017-07-20 2017-09-22 广东药科大学 A kind of method for differentiating sophora flower quality based on colour difference meter method
CN107389564A (en) * 2017-07-26 2017-11-24 成都中医药大学 A kind of method for differentiating stir-baked RHIZOMA ATRACTYLDIS MACROCEPHALAE in bran and processing the duration and degree of heating
CN110261323A (en) * 2019-06-21 2019-09-20 广东一方制药有限公司 An online evaluation method of dog ridge processing technology
CN110441255A (en) * 2019-08-27 2019-11-12 广东一方制药有限公司 A kind of detection method of processed products of Fructus Gardeniae
CN111323379A (en) * 2020-04-23 2020-06-23 山东省中医药研究院 A method for judging the processing quality of arborvitae charcoal

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王晓红: "《设计色彩学》", 30 September 2018, 复旦大学出版社 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115326726A (en) * 2022-08-12 2022-11-11 粤海永顺泰(广州)麦芽有限公司 Malt chroma detection method
CN115326726B (en) * 2022-08-12 2024-06-04 粤海永顺泰(广州)麦芽有限公司 Malt chroma detection method

Similar Documents

Publication Publication Date Title
Kek et al. Total phenolic contents and colour intensity of Malaysian honeys from the Apis spp. and Trigona spp. bees
Li et al. Total phenolic, flavonoid content, and antioxidant activity of flour, noodles, and steamed bread made from different colored wheat grains by three milling methods
Oloniyo et al. Orange‐fleshed sweet potatoes composite bread: A good carrier of beta (β)‐carotene and antioxidant properties
CN106173013B (en) A kind of processing method of the Fu-brick tea containing leaf of Moringa
Shori et al. Total phenols, antioxidant activity and sensory evaluation of bread fortified with spearmint
CN111795877A (en) Digital quality control method for chromaticity of fructus psoraleae
CN102042978A (en) Colorimetric card for quickly judging grades of Chinese medicinal materials and preparation method thereof
CN105326686B (en) A kind of skin whitening, moisturizing facial treatment mask
CN111487202A (en) Method for controlling processing process of cattail pollen on line
Chand et al. Effect of process parameters on quality of dried nettle leaves
CN105831289A (en) Nutritional health vegetable blend oil and preparation method thereof
Rajashree et al. Amla, ashwagandha and shatavari formulations as herbal medicines and nutraceuticals
Guo et al. Progress in the design and quality control of placeboes for clinical trials of traditional Chinese medicine
CN105105123A (en) Lycium ruthenicum health tablet and preparation method thereof
Göksu et al. Rhubarb powder: Potential uses as a functional bread ingredient
CN115541507A (en) A kind of chromatic quality detection method of salvia miltiorrhiza
TWI674103B (en) Extracts of dragon fruit flower, preparation method for the same, use, and skin complexion improved compositions thereof
CN110302111B (en) Antioxidant gel mask, preparation method and application
CN108272728B (en) Facial mask with whitening and freckle removing functions
Prajapat et al. Physico-chemical evaluation of guduchyadi kwatha for instant use: An ayurvedic herbal formulation
Chikwendu Comparative evaluation of chemical composition of fermented ground bean flour (Kerstingella geocarpa), cowpea flour (Vigna unguiculata) and commercial wheat flour (Triticum spp.)
CN108403531A (en) Purposes of the moldavica dragonhead extractive in preparing whitening cosmetics
Upton Nomenclature: Herbal Taxonomy in the Global Commerce of Botanicals
CN108157969A (en) A kind of blood-enriching face-nourishing composition and preparation method thereof
Wabali Bioactive Compounds, Amino Acid Content/Score of Composite Wheat, African Walnut, Moringa Biscuits

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20201020

RJ01 Rejection of invention patent application after publication